Vardi J, Graff E, Oberman Z, Flechter S, Rabey J M
Isr J Med Sci. 1984 May;20(5):407-9.
Parkinsonian patients are usually given several drugs concomitantly with bromocriptine, with variable results. The possibility of interference of these drugs with the availability of bromocriptine in the brain was investigated by measuring bromocriptine concentrations in the striatum in rats. After a single injection, bromocriptine concentration in the striatum was 13.1 +/- 2.9 ng/mg protein. Naloxone, an opiate receptor blocker, was found to produce the largest increase in bromocriptine content (21.7 +/- 2.5 ng/mg protein). Amantadine, diazepam and haloperidol produced the largest decreases (3.2 +/- 0.9, 3.3 +/- 0.8 and 4.4 +/- 1.2 ng/mg protein, respectively). Rats given L-dopa or benzodiazepine also showed slightly lower levels of bromocriptine.
帕金森病患者通常会同时服用几种药物和溴隐亭,结果各不相同。通过测量大鼠纹状体中溴隐亭的浓度,研究了这些药物干扰溴隐亭在大脑中可用性的可能性。单次注射后,纹状体中溴隐亭的浓度为13.1±2.9纳克/毫克蛋白质。发现阿片受体阻滞剂纳洛酮可使溴隐亭含量增加最多(21.7±2.5纳克/毫克蛋白质)。金刚烷胺、地西泮和氟哌啶醇使溴隐亭含量下降最多(分别为3.2±0.9、3.3±0.8和4.4±1.2纳克/毫克蛋白质)。服用左旋多巴或苯二氮卓类药物的大鼠,其溴隐亭水平也略低。